tradingkey.logo

CareDx Inc

CDNA
14.770USD
-0.230-1.53%
收盘 11/03, 16:00美东报价延迟15分钟
786.06M总市值
15.21市盈率 TTM

CareDx Inc

14.770
-0.230-1.53%

关于 CareDx Inc 公司

CareDx, Inc. 是一家精准医疗解决方案公司。该公司专注于发现、开发和商业化针对移植患者和护理人员的临床差异化诊断解决方案。该公司在移植前后的患者旅程中提供检测服务、产品以及患者和数字解决方案,并为移植患者提供基于基因组学的信息。其商业化的检测服务包括 AlloSure Kidney(一种用于肾移植患者的供体来源的无细胞 DNA (dd-cfDNA) 解决方案);AlloMap Heart(一种用于心脏移植患者的基因表达解决方案);AlloSure Heart(一种用于心脏移植患者的 dd-cfDNA 解决方案)和 AlloSure Lung(一种用于肺移植患者的 dd-cfDNA 解决方案)。该公司的产品组合包括 AlloSeq Tx、QTYPE、Olerup SSP、AlloSeq HCT 和 AlloSeq cfDNA。它为各种移植接受者开发并提供诊断监测检测服务。

CareDx Inc简介

公司代码CDNA
公司名称CareDx Inc
上市日期Jul 17, 2014
CEOMr. John W. Hanna
员工数量644
证券类型Ordinary Share
年结日Jul 17
公司地址8000 Marina Blvd
城市BRISBANE
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编94005
电话14152872300
网址https://www.caredx.com/
公司代码CDNA
上市日期Jul 17, 2014
CEOMr. John W. Hanna

CareDx Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Peter Maag, Ph.D.
Dr. Peter Maag, Ph.D.
Independent Director
Independent Director
298.28K
-3.24%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
145.40K
+1.22%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
144.69K
+9.13%
Ms. Jessica Meng
Ms. Jessica Meng
Chief Commercial Officer
Chief Commercial Officer
109.63K
-4.11%
Mr. William A. (Bill) Hagstrom
Mr. William A. (Bill) Hagstrom
Independent Director
Independent Director
43.41K
--
Mr. Nathan Smith
Mr. Nathan Smith
Chief Financial Officer
Chief Financial Officer
42.00K
--
Ms. Christine M. Cournoyer
Ms. Christine M. Cournoyer
Independent Director
Independent Director
38.58K
+45.71%
Mr. Suresh Gunasekaran
Mr. Suresh Gunasekaran
Director
Director
27.45K
--
Mr. Jeffrey Adam Novack
Mr. Jeffrey Adam Novack
General Counsel, Secretary
General Counsel, Secretary
25.20K
-18.08%
Ms. Caroline Corner
Ms. Caroline Corner
Investor Relations
Investor Relations
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Peter Maag, Ph.D.
Dr. Peter Maag, Ph.D.
Independent Director
Independent Director
298.28K
-3.24%
Mr. Michael D. Goldberg
Mr. Michael D. Goldberg
Independent Chairman of the Board
Independent Chairman of the Board
145.40K
+1.22%
Dr. Frederick E. (Fred) Cohen, M.D.
Dr. Frederick E. (Fred) Cohen, M.D.
Independent Director
Independent Director
144.69K
+9.13%
Ms. Jessica Meng
Ms. Jessica Meng
Chief Commercial Officer
Chief Commercial Officer
109.63K
-4.11%
Mr. William A. (Bill) Hagstrom
Mr. William A. (Bill) Hagstrom
Independent Director
Independent Director
43.41K
--
Mr. Nathan Smith
Mr. Nathan Smith
Chief Financial Officer
Chief Financial Officer
42.00K
--

收入明细

FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Testing Service revenue
62.03M
0.00%
Digital and other revenue
12.81M
0.00%
Product revenue
11.83M
0.00%
地区USD
名称
营收
占比
United States
81.64M
0.00%
Rest of the world
5.04M
0.00%
业务
地区
业务USD
名称
营收
占比
Testing Service revenue
62.03M
0.00%
Digital and other revenue
12.81M
0.00%
Product revenue
11.83M
0.00%

股东统计

更新时间: 8月15日 周五
更新时间: 8月15日 周五
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
7.64%
The Vanguard Group, Inc.
7.04%
Baron Capital Management, Inc.
4.58%
State Street Investment Management (US)
4.10%
ARK Investment Management LLC
3.95%
其他
72.70%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
7.64%
The Vanguard Group, Inc.
7.04%
Baron Capital Management, Inc.
4.58%
State Street Investment Management (US)
4.10%
ARK Investment Management LLC
3.95%
其他
72.70%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
44.54%
Investment Advisor
41.49%
Hedge Fund
10.63%
Individual Investor
3.71%
Research Firm
2.37%
Pension Fund
0.67%
Bank and Trust
0.37%
Insurance Company
0.04%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
443
53.30M
100.13%
-9.09M
2025Q2
458
57.19M
107.22%
-3.81M
2025Q1
463
58.20M
104.56%
-2.86M
2024Q4
457
54.99M
99.23%
-4.48M
2024Q3
452
53.78M
101.72%
-11.43M
2024Q2
424
54.82M
104.96%
-13.18M
2024Q1
450
55.58M
107.13%
-14.92M
2023Q4
462
54.27M
100.29%
-16.52M
2023Q3
493
55.98M
103.34%
-21.97M
2023Q2
517
57.57M
107.02%
-21.82M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
4.07M
7.64%
-142.46K
-3.39%
Jun 30, 2025
The Vanguard Group, Inc.
4.90M
9.21%
+76.50K
+1.59%
Jun 30, 2025
Baron Capital Management, Inc.
2.44M
4.58%
+245.65K
+11.22%
Jun 30, 2025
State Street Investment Management (US)
2.18M
4.1%
-304.45K
-12.25%
Jun 30, 2025
ARK Investment Management LLC
2.10M
3.95%
-247.22K
-10.53%
Jun 30, 2025
Ophir Asset Management Pty Ltd
1.89M
3.56%
+274.63K
+16.97%
Jun 30, 2025
Hood River Capital Management LLC
1.77M
3.32%
+182.03K
+11.49%
Jun 30, 2025
Amova Asset Management Co., Ltd.
1.24M
2.32%
-139.83K
-10.16%
Jun 30, 2025
Gagnon Securities LLC
2.13M
4.01%
+585.21K
+37.78%
Jul 17, 2025
Invesco Advisers, Inc.
1.70M
3.2%
-182.17K
-9.67%
Jun 30, 2025
查看更多

持股ETF

更新时间: 11月2日 周日
更新时间: 11月2日 周日
机构名称
占比
ARK Genomic Revolution ETF
3.04%
ROBO Global Healthcare Technology & Innovation ETF
1.62%
Global X Genomics & Biotechnology ETF
0.87%
Franklin Genomic Advancements ETF
0.58%
SPDR S&P Biotech ETF
0.34%
First Trust Small Cap Growth AlphaDEX Fund
0.27%
Direxion Daily S&P Biotech Bull 3X Shares
0.2%
iShares Micro-Cap ETF
0.17%
First Trust Small Cap Core Alphadex Fund
0.13%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.12%
查看更多
ARK Genomic Revolution ETF
占比3.04%
ROBO Global Healthcare Technology & Innovation ETF
占比1.62%
Global X Genomics & Biotechnology ETF
占比0.87%
Franklin Genomic Advancements ETF
占比0.58%
SPDR S&P Biotech ETF
占比0.34%
First Trust Small Cap Growth AlphaDEX Fund
占比0.27%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.2%
iShares Micro-Cap ETF
占比0.17%
First Trust Small Cap Core Alphadex Fund
占比0.13%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.12%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
KeyAI